We describe a radioimmunoassay for 1,25-dihydroxycholecalciferol in human serum. We raised antisera in rabbits to 1,25-dihydroxycholecalciferol-3-hemisuccinate coupled to bovine serum albumin, and obtained sensitive, high-titer antibodies. These antibodies had a high affinity for 1,25-dihydroxycholecalciferol and cross reacted mainly with 25-hydroxycholecalciferol and 24, 25-dihydroxycholecalciferol. Addition of 1 mL of normal rabbit serum per liter reduced this interference to 5 and 4%, respectively. However, these interfering steroids are present in large excess, so extensive purification of 1,25-dihydroxycholecalciferol from serum is necessary. The steroid was extracted with ethyl acetate/cyclohexane, purified on Sephadex LH-20, and then chromatographed on a column of silicic acid. The radioimmunoassay is sensitive to 5 pg/tube (3 ng/L of serum). The between-assay CV was 14%. The mean concentration of 1,25-dihydroxycholecalciferol in the serum of 54 healthy adults was 38 (SD 12) ng/L, with no sex-related difference. The assay was further validated by the finding of low or undetectable concentrations in patients with chronic renal failure and of increased concentrations in the serum of patients with primary hyperparathyroidism.
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We describe a radioimmunoassay for 1,25-dihydroxycholecalciferol in human serum. We raised antisera in rabbits to 1,25-dihydroxycholecalciferol-3-hemisuccinate coupled to bovine serum albumin, and obtained sensitive, high-titer antibodies. These antibodies had a high affinity for 1, 25-dihydroxycholecalciferol and cross reacted mainly with 25-hydroxycholecalciferol and 24, 25-dihydroxycholecalciferol. Addition of 1 mL of normal rabbit serum per liter reduced this interference to 5 and 4%, respectively. However, these interfering steroids are present in large excess, so extensive purification of 1,25-dihydroxycholecalciferol from serum is necessary. The steroid was extracted with ethyl acetate/cyclohexane, purified on Sephadex LH-20, and then chromatographed on a column of silicic acid. The radioimmunoassay is sensitive to 5 pg/tube (3 ng/L of serum). The between-assay CV was 14%. The mean concentration of 1,25-dihydroxycholecalciferol in the serum of 54 healthy adults was 38 (SD 12) ng/L, with no sex-related difference. The assay was further validated by the finding of low or undetectable concentrations in patients with chronic renal failure and of increased concentrations in the serum of patients with primary hyperparathyroidism.
In comparison with previously described methods, the major advantage of the present assay is the use of stable gamma-globulins, which are available in large amounts, as binding protein. 
age-related effects
Cholecalciferol is metabolized in the liver to 25-hydroxycholecalciferol;
further hydroxylation can then occur at either position 24 or 26, probably representing biological inactivation, or at position 1, resulting in 1,25-dihydroxycholecalciferol,a biologically highly active compound (1). Many assays have been described for measuring 25-bydroxycholecalciferol, and its concentration in plasma reflects the status of the organism with regard to its access to nutritional or skin-produced cholecalciferol (2) (3) (4) (5) (6) (7) (8) (9) . However, the We therefore tried to raise antibodies to, and to develop a radioimmunoassay for, 1,25-dihydroxycholecalciferol. (Figure 1,3) . A solution of 500 mg of la,25-
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(2) in 200 mL of a 4:1 mixture of spectroscopic grade n-hexane and tetrahydrofuran was irradiated at 0 #{176}C with a medium-pressure mercury lamp (Hanovia, 450 W) through quartz glass, until approximately 50% of the starting material was converted.
After the solvents were evaporated, the components of the photolysis mixture were separated by use of a Waters Associates high-performance liquid chromatograph, Model 244, and a 245cm X 1 cm Porasil A column, eluted with a mixture of n-hexane-ethyl acetate (1.5/1 by vol) to give 216 mg of recovered starting material and 162 mg of hr,25-dihy- 3 tL of tri-n-butylamine and 1.5 tL of isobutylchlorocarbonate were added and the mixture was cooled at 4 #{176}C, then added to 1 mL of bovine serum albumin (34 mg, diluted in dioxane/water, 1/1 by vol, previously adjusted to pH 9.2 with sodium hydroxide, 1 mol/L solution). The pH was kept between 8.5 and 9 by adding minute amounts of the sodium hydroxide solution. After magnetic mixing for 4 h at 4 #{176}C, the solution was applied on the top of a 0.9 X 20 cm Sephadex G-50 (fine) column and eluted with a sodium phosphate buffer (0.1 mol/L, pH 7.2). Two ultraviolet-absorbing peaks were seen. The first one corresponded to the protein-steroid conjugate and was stored in small aliquots at -20 #{176}C. The second corresponded to the unreacted 1,25-dihydroxycholecalciferol-3-hemisuccinate.
Eighty percent of the steroid was incorporated into bovine serum albumin, as calculated from the difference in absorbance at 265 nm between normal bovine serum albumin and the protein-steroid conjugate.This represents a 15/1 molar ratio of steroid to bovine serum albumin.
Immunization. Twelve female rabbits (three months old) were immunized by multiple intradermal injections of various amounts of immunogen emulsified in 1 mL of complete Freund's adjuvant.
At monthly intervals-thereafter, the same mixture was given subcutaneously.
Ten days later, blood was according to the previously monitored position of the stable steroid (10 ng) . After a running time of 19 mm a signal is given fromthewin' to the three-way valve to switch the solvent to the waste collector for the next 11 mm (for washing the column) and to reset the fraction collector at the fIrst position of the next row of tubes. ThIrty minutes after the first Injection the next sample is injected, and at that time a new signal leaves the wise to the three-wayvalveand the fraction collector to start the next collection as above taken from an ear vein and the serum was stored at -20 #{176}C until used. Three rabbits who had received more than 0.5 mg of the conjugate died within two months, from hypercalcemia (serum calcium >150 mg/L). Four other rabbits were killed after five months because their serum was of low titer and low affinity for 1,25-dihydroxycholecalciferol.
Two of them had received a monthly dose of 250 zg of immunogen; the other two, 125 Mg. The best antiserum was obtained in rabbit H after 10 monthly injections of 250 g of immunogen, and we used this antiserum in the present study. 
Assay Methodology
Results
Antiserum Production
Rabbits immunized with 1,25-dihydroxycholecalciferol-3-hemisuccinate, coupled to bovine serum albumin, developed antisera against this new immunogen.
Indeed, there are several reasons to believe that 1, 25- Incubation was performed as described in t.4efhods, radlolmmunoesuy precipitated in the '.globulin fraction on fractionation with ammonium sulfate. Moreover, the steroid specificity of these antisera differed markedly from that of the vitamin 1)-binding protein (20, 21) . Figure 3 shows the titer and affinity for I ,25-dihydroxycholecalciferol of six of these antisera.
Extraction and Purification of Plasma 1,25-Dihydroxycholecalciferol
Extraction of l,25-dihydroxycholecalciferol from plasma with an equal volume of an equivolume mixture of ethyl acetate and cyclohexane was found to he efficient; 93% (SI) 1%, n = 5) of the labeled steroid could he recovered.
On,ly 73% t labeled 25-hydroxycholecakiferol could be extracted by this procedure.
The analytical recovery of radioactive 1,25-dihy. droxycholecalciferol on the Sephadex LH-20 columns was 76% (SD 2%, n = 5). The overall analytical recovery after plasma extraction, chromatography on Sephadex LH-20, and liquid chromatography, monitored systematically by adding labeled 1,25-dihydroxycholecalciferol, was 54% (SO 4%) for 50 con. secutive plasma samples.
Precision, Sensitivity, and Recovery
The between-and within-assay CV's, estimated by the repeated measurement of a pool of human serum containing 42 pg of l,25-dihydroxycholecnlciferol per milliliter, were 14% (n 25) and 11% (n = 5), respectively.
The sensitivity of the system, defined as the point two standard deviations below the R (40% of the total radioactivity), was 5 pg. This corresponds to a sensitivity of :3to 4 ng/L when 5 mL of serum is extracted and processed as described.
We measured I ,25-dihydroxycholecakiferol in four samples after extraction from 5 or 2.5 mL of serum. The amount of l,25-dihydroxycholecalciforol measured in the 2.5 mL extract was 47% (SD 1%) of the amount found in the 5-mL extract.
Analytical recovery was estimated itt two levels: when 50 or 1(X) pg of 1,25-dihydroxycholecalciferol was added to 5 mL of plasma, 52% (SI) 10%, n -4) and 103% (SI)1M%, a -7) of the added amount was recovered, respectively.
Specificity
The antiserum against 1,25-dihydroxycholucalciferol.3. hemisuccinate was not specific for I ,25-dihydroxycholecalciferol. In the absence of added normal rabbit serum the most cross-reactive steroids were 25-hydroxycholecalcif'erol (33%) and 24,25-dihydroxycholecalciferol (10%). However, addition of 1 mL of normal rabbit serum per liter decreased the cross reactivity of these metabolites to 5 and 4%, respectively (Figure 4 ciferol( Figure 5 ).
Discussion
Because 1,25-dihydroxycholecalciferol is important in calcium homeostasis, its measurement has many potential investigational and clinical applications. In the most widely used assays, however, a chick intestinal receptor protein is used, which requires specific conditions for its conservation (12, 22) and necessitates a regular supply and handling of rachitic chicks (7) (8) (9) (10) (11) (12) . The production of antibodies against vitamin I) metabolites, although theoretically possible in view of the experience with other steroids, has been hampered by the lack of suitable immunogens. 1,25-Dihydroxycholecalciferol-25-hemisuccinate coupled to bovine serum albumin reportedly is immunogenic (23, 24) . We used a similar immun()gen, differing only in the position of the hemisuccinate at the first hydroxyl group of the steroid, but our prolonged immunization resulted in antibodies with a higher titer and better affinity for 1,25-dihydroxycholecalciferol.
The antibody, however, reacts with several vitamin D metabolites and even seems to recognize the 25-hydroxyl group better than the 1-hydroxyl group ( Figure 5 ). The addition of a small amount of normal rabbit serum (1 mL/L) markedly enhances the specificity of the radioimmunoassay for 1,25-dihydroxycholecalciferol.
This can be explained by the presence of the the natural vitamin D-binding protein, which has a much higher affinity for 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol than for the most active steroid (20, 21) . The specificity of our assay still necessitates extensive purification of the steroid because the competing substances are present in the serum in 100-to 1000-fold excess (2) (3) (4) (5) (6) (7) (8) (9) .
Although the assays in which intestinal receptor is used are a little more specific than our radioimmunoassay, a similar purification of 1,25-dihydroxycholecalciferol is required to remove nonspecific interfering substances (7) (8) (9) (10) (11) (12) .
The cross reactivity of our assay for 1,25-dihydroxyergocalciferol could not be tested, but the antiserum discriminates well between 25-hydroxycholecalciferol and 25-hydroxyergocalciferol, so that the ergocalciferol metabolites might not be completely detected in our assay. This would then imply that our antibody assay underestimates the concentration of biologically active vitamin D metabolites in vitamin D2-treated subjects.
Our assay procedure follows the general scheme previously used by others (7) (8) (9) (10) (11) (12) .
Extraction of the steroid with ethyl acetate/cyclohexane is at least as efficient as, but much simpler than, previously used techniques (7) (8) (9) (10) (11) (12) (13) (14) .
The dimensions of the Sephadex LH-20 column were kept to a minimum, and this step was only included to decrease the amount of lipid that would be injected into the chromatograph.
The use of an automatic sample injector coupled to an automatic sample collector permits handling of many samples without the constant attendance of a technician. The sensitivity of the assay was optimized by using a small incubation volume and non-equilibrium conditions. A similar sensitivity can be obtained by the recent adaptations (8, 9) of the receptor assay in which tracers of high specific activity are used.
Results obtained with our radioimmunoassay correspond well to those obtained previously with other methods (7) (8) (9) (10) (11) (12) (14) . Both of these techniques were only applied to a few samples. Low or undetectable concentrations of 1,25-dihydroxycholecalciferol in serum were found in patients with nonfunctional or no kidneys ( Figure 5 ), as could be expected for a hormone produced exclusively in the kidney (1). Increased concentrations were observed in serum of patients with primary hyperparathyroidism, probably related to the stimulatory effect of excess parathyrin and low phosphorus concentrations (1). In some elderly subjects, unexplicably low concentrations of 1,25-dihydroxycholecalciferol were found, but it remains to be explored whether this represents a normal phenomenon of aging or a real disease.
The present report thus confirms that a radioimmunoassay for 1,25-dihydroxycholecalciferol is feasible but requires ex- lower limit of detection; M, mean tensive preliminary purification of the steroid, because serum contains a large excess of related metabolites that compete with the antiserum.
The radioimmunoassay has the advantage of a stable gamma-globulin, which can be produced in large amounts, instead of the more labile natural receptor protein from rachitic chicks. The sensitivity of the present assay is comparable to that of previously reported methods and gives much the same results as they for normal and pathological human sera. Clemens et al. (25) recently described a radioimmunoassay for 1,25-dihydroxycholecalciferol with use of similar general procedures, but the antibodies were raised against I ,25-dihydroxycholecalciferol-25-hemisuccinate. Their assay is slightly less sensitive than ours and the cross reaction with other vitamin D metabolites was higher, because no normal rabbit vitamin D-binding protein was added. The intrinsic cross reactivity of their and our antibodies are, however, quite similar. The use of other immunogens, exposing both the A ring and the side chain of the steroid may result in more specific antisera, reducing the technical difficulties involved in all the currently available methods.
